Although the routine immunisation of children against influenza is not obligatory, influenza A viruses are an important cause of illness in infants and young children (Fox and Kilbourne, 1973) and can cause serious morbidity and even death in children of any age with chronic heart, respiratory, and other underlying disease (Phillips et al., 1973; Glezen, 1977) . Unfortunately, conventional, inactivated whole influenza virus vaccines are reactogenic in infants and young children (Marine and Stuart-Harris, 1976; Wright et al., 1976) , and this has prohibited their use in this cohort of the population. Studies comparing whole, inactivated influenza virus vaccines with split or the more highly purified subunit influenza virus vaccines in adults have shown the latter to be less reactogenic (Brandon et al., 1967; Barry et al., 1976) . It is, therefore, considered possible that these vaccines may be more acceptable for children.
In the present study, an assessment of the reactogenicity and immunogenicity of a bivalent influenza virus vaccine containing only the haemagglutinin and neuraminidase surface antigens of A/Victoria/75 and B/Hong Kong/73 influenza viruses was carried out in young children. The surface antigens of these Received for publication 29 November 1978 viruses were adsorbed to aluminium hydroxide gel. A similar, surface-antigen-adsorbed vaccine has been shown to induce few reactions and good serum antibody responses in adults (Potter et al., 1975 (Potter et al., , 1977 .
Material and methods

VACCINE
The adsorbed, surface-antigen influenzavirusvaccine, Fluvirin, manufactured by Evans Biologicals for Duncan Flockhart Ltd, was used in the present study. The vaccine was prepared from egg-grown virus and purified by zonal centrifugation; the surface antigens of the intact virus particle, the haemagglutinin (HA) and neuraminidase (N), were separated from unwanted core material by centrifugation through a sucrose gradient containing Triton N 101 and then adsorbed on to an aluminium hydroxide gel (Brady and Furminger, 1976) . Before adsorption on to the gel, rocket immunoelectrophoresis (Oxford and Schild, 1978) SEROLOGICAL STUDIES Paired sera were tested for haemagglutinationinhibiting (HI) antibodies using 8 haemagglutinating units of virus and employing the microtitre technique (Sever, 1962) .
The sera were pretreated with cholera filtrate to remove non-specific inhibitors and tested for HI antibodies to the homologous A/Victoria/75 and B/Hong Kong/73 viruses.
Assays for neuraminidase-inhibiting (NI) antibodies were carried out by an automated modification (Bevan et al., 1975) 
Results
CLINICAL REACTIONS
The clinical reactions attributable to the vaccine were mild, and the findings are shown in Table 1 . Of 49 children, 18 (37%) developed mild local reactions consisting of slight soreness and aching at the inoculation site at some time during the three days after immunization. Two of these children also had local swellings, two had redness, and one a bruise at the inoculation site. The incidence of systemic reactions was also low in the present study, and only one child, a 7-year-old diabetic girl, with normally stable diabetes, had a systemic reaction apparently associated with immunization. This child showed raised levels of sugar and ketones in the urine for two days after immunisation but no other effects. In addition, one boy suffered an asthmatic attack 36 hours after immunization. Although temperatures were not recorded, there were no reports of fever after immunisation in any of the children.
SERUM ANTIBODY RESPONSES AFTER IMMUNISATION
The serum HI antibody responses of the volunteers to the bivalent A/Victoria/75 and B/Hong Kong/73 influenza virus vaccine are shown in Table 2 . A total of 23 (47%) of the 49 children responded to immunisation with four-fold rises in serum HI antibody titre to influenza A/Victoria/75. The geometric mean titre (gmt) of this antibody rose from 17-2 preimmunisation to 67-4 four to six weeks after immunisation, an increase of 3-9-fold. In addition, the number of children with serum HI antibody levels of 3 1 :40 to A/Victoria/75 rose from 14 (29 %) to 29 (59 %) after immunisation.
The serum HI antibody response to the B/Hong Kong/73 component of the vaccine is also shown in Table 2 . Seventeen (35 %) of the 49 children responded with 3 4-fold serum HI antibody increases to this virus, and the gmt rose from 5-9 to 15-7, an increase of 2-7-fold.
The serum NI antibody response of the children to immunisation with the A/Victoria/75 :B/Hong Kong/73 influenza virus vaccine is also presented in Table 2 . Owing to the small volume of serum avail- 
Discussion
Several workers have reported adverse local and systemic reactions after the use of conventional, inactivated, whole virus vaccines in children (Parkman et al., 1976; Wright et al., 1976; Schevill and Marks, 1977) and particularly in infants (Marine and Stuart-Harris, 1976; Wright et al., 1976) . The present results suggest that the A/Victoria/75 :B/Hong Kong/73 surface-antigenadsorbed vaccine used in the present study is both safe and acceptable in children aged 4 years or older. The local systemic reactions after vaccine administrations were mild, and this is in accordance with the findings in adults receiving surface-antigen-adsorbed vaccine (Potter et al., 1977) . This may well apply generally to subunit and split influenza virus vaccines (Davenport et al., 1964; Phillips et al., 1973) . Recent studies in both infants and children showed that a split-product A/Port Chalmers/ 73 :B/Hong Kong/73 influenza virus vaccine produced markedly fewer systemic reactions than a conventional whole virus vaccine given at an equivalent dose. The present studies did not extend to infants, and the reactogenicity of surface-antigenadsorbed vaccine in this group has yet to be determined. The serological response of adults to surfaceantigen-adsorbed influenza virus vaccine was found to be good (Potter et al., 1977) Hobson et al., 1972) , increased from 29 to 59 after immunisation. Other workers have shown that children respond less well than adults to subunit or split influenza vaccines (Parkman et al., 1976) , and young persons unprimed with the swine influenza virus respond poorly to split A/New Jersey/76 virus vaccine . The influenza B/Hong Kong/73 component of split virus vaccine has been shown to be a poor immunogen in children under 10 years of age , and the results of the present study are in agreement with these findings.
The poor response of children is almost certainly due to their relative lack of prior exposure to influenza viruses, and this view is supported by the similarly poor response of young adults even to whole virus vaccines containing antigens to which they were unprimed. For this reason it seems probable that a second, booster dose of subunit influenza vaccine will be required to afford adequate protection in a population which has not experienced the relevant influenza virus strains.
The serological response of children in the present study to the A/Victoria/75 and B/Hong Kong/73 neuraminidase antigens was similar to that seen for the HA antigens, and less than half of the subjects tested showed significant serum NI antibody responses. However, the gmt of serum NI antibody was increased in the group as a whole, and high levels of this antibody may contribute to protection against influenza (Monto and Kendal, 1973) .
In conclusion, these studies show that the surfaceantigen-adsorbed vaccine used is of low reactogenicity in children 4 to 11 years of age and induces significant serum HI and NI antibody responses. 
